Skip to the page

Data / Drug companies / Darmerica, LLC

Darmerica, LLC: 211 products in the FDA NDC directory, labeler code 71052

Darmerica, LLC (labeler code 71052) lists 211 products in the FDA National Drug Code Directory. By type: 211 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on July 17, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71052
Products in commercial distribution
211
Packages
789
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
21
Products with a marketing end date set
58
Earliest marketing start
June 1, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients20295.7%
Bulk ingredients for compounding94.3%

Products by type

TypeProductsShare
Bulk ingredients211100%

Dosage forms

Dosage formProductsShare
Powder21099.5%
Oil10.5%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Clascoterone71052-174PowderBulk ingredients for compoundingJuly 17, 2026
Estradiol hemihydrate71052-165PowderBulk ingredientsJune 1, 2026
Leucovorin calcium71052-164PowderBulk ingredientsApril 21, 2026
Iron sucrose71052-162PowderBulk ingredients for compoundingApril 20, 2026
Mots-c acetate71052-156PowderBulk ingredientsJanuary 14, 2026
Melanotan ii acetate71052-154PowderBulk ingredientsJanuary 13, 2026
Humanin acetate71052-153PowderBulk ingredientsJanuary 13, 2026
Met-enkephalin acetate71052-144PowderBulk ingredientsJanuary 13, 2026
Kisspeptin-10 acetate71052-141PowderBulk ingredientsJanuary 13, 2026
Gonadorelin acetate71052-137PowderBulk ingredientsJanuary 13, 2026
Setmelanotide (rm-493) acetate71052-136PowderBulk ingredientsJanuary 13, 2026
Larazotide acetate71052-096PowderBulk ingredientsJanuary 13, 2026
Elamipretide (ss-31) acetate71052-095PowderBulk ingredientsJanuary 13, 2026
Ara290 acetate71052-094PowderBulk ingredientsJanuary 13, 2026
Hexarelin acetate71052-092PowderBulk ingredientsJanuary 13, 2026
Selank acetate71052-090PowderBulk ingredients for compoundingJanuary 13, 2026
Long r3 igf-171052-085PowderBulk ingredientsJanuary 13, 2026
Bremelanotide acetate71052-084PowderBulk ingredients for compoundingJanuary 13, 2026
Buserelin acetate71052-083PowderBulk ingredientsJanuary 13, 2026
Vasoactive intestinal peptide (vip) acetate71052-148PowderBulk ingredientsJanuary 12, 2026
Acth 1-24 (tetracosactide acetate)71052-082PowderBulk ingredientsJanuary 12, 2026
L-carnitine71052-081PowderBulk ingredientsOctober 28, 2025
Cholecalciferol71052-080PowderBulk ingredientsJune 9, 2025
Progesterone71052-079PowderBulk ingredientsJune 3, 2025
Slu-pp-33271052-078PowderBulk ingredientsMay 27, 2025

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.